Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 3/20 | 0.82 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.78 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.78 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.78 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.78 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.78 |
| ▸ | DRD2 | P14416 | 2/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.78 |
| ▸ | HTR7 | P34969 | 2/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.78 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.77 |
| ▸ | DRD4 | P21917 | 1/20 | 0.77 |
| ▸ | FPR3 | P25089 | 1/20 | 0.77 |
| ▸ | HTR1D | P28221 | 1/20 | 0.77 |
| ▸ | HTR1B | P28222 | 1/20 | 0.77 |
| ▸ | GPR183 | P32249 | 1/20 | 0.77 |
| ▸ | HRH1 | P35367 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13534461 | 0.91 | HTR1A (0.83) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| SCHEMBL16965324 | 0.91 | HTR1A (0.83) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| SCHEMBL3737391 | 0.90 | HTR1A (1.00) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| SCHEMBL13532804 | 0.90 | HTR1A (0.82) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| SCHEMBL15782597 | 0.89 | HTR1A (0.81) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| Vilazodone SCHEMBL4423647 | 0.88 | HTR1A (1.00) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| Vilazodone SCHEMBL29357448 | 0.88 | HTR1A (1.00) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| Vilazodone SCHEMBL650682 | 0.88 | HTR1A (1.00) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| Vilazodone SCHEMBL30051446 | 0.88 | HTR1A (1.00) | HTR1AADRA2AADRA2CADRA1DADRA1A | |
| SCHEMBL30931545 | 0.88 | HTR1A (0.81) | HTR1AADRA2AADRA2CADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4268802-A1 | VILAZODONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Yonsun Biotechnology Co., Ltd. (CN) | 2023-11-01 | — | — | EP | disclosed |
| US-20230285405-A1 | Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses | THE UNIVERSITY OF CHICAGO (US) | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230285405-A1 | Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses | CTRB1, CMA1, MAN2B1 | HTR1A 198/4885ADRA2A 94/4885ADRA2C 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.